117 related articles for article (PubMed ID: 12423230)
1. Plasma concentrations of trimethoprim and sulfamethoxazole in llamas after orogastric administration.
Snook CS; Poppenga RH; Rudik I; Sweeney RW
J Vet Pharmacol Ther; 2002 Oct; 25(5):383-6. PubMed ID: 12423230
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics and bioavailability of trimethoprim-sulfamethoxazole in alpacas.
Chakwenya J; Lakritz J; Tyler J; Fales WH; James-Kracke M; Smith K; Holle J
J Vet Pharmacol Ther; 2002 Oct; 25(5):321-7. PubMed ID: 12423221
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after oral single- and multiple-dose administration to healthy pigs.
Mengelers MJ; van Gogh ER; Huveneers MB; Hougee PE; Kuiper HA; Pijpers A; Verheijden JH; van Miert AS
Vet Res Commun; 2001 Aug; 25(6):461-81. PubMed ID: 11519678
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of sulfamethoxazole and trimethoprim in donkeys, mules, and horses.
Peck KE; Matthews NS; Taylor TS; Mealey KL
Am J Vet Res; 2002 Mar; 63(3):349-53. PubMed ID: 11911569
[TBL] [Abstract][Full Text] [Related]
5. Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients.
Ribera E; Pou L; Fernandez-Sola A; Campos F; Lopez RM; Ocaña I; Ruiz I; Pahissa A
Antimicrob Agents Chemother; 2001 Nov; 45(11):3238-41. PubMed ID: 11600390
[TBL] [Abstract][Full Text] [Related]
6. Disposition of sulfadimethoxine in male llamas (Llama glama) after single intravenous and oral administrations.
Junkins K; Boothe DM; Jensen J; Herzog T; Chatfield J
J Zoo Wildl Med; 2003 Mar; 34(1):9-15. PubMed ID: 12723795
[TBL] [Abstract][Full Text] [Related]
7. Trimethoprim/sulfamethoxazole does not affect the steady-state disposition of indinavir.
Sturgill MG; Seibold JR; Boruchoff SE; Yeh KC; Haddix H; Deutsch P
J Clin Pharmacol; 1999 Oct; 39(10):1077-84. PubMed ID: 10516943
[TBL] [Abstract][Full Text] [Related]
8. The disposition of five therapeutically important antimicrobial agents in llamas.
Christensen JM; Smith BB; Murdane SB; Hollingshead N
J Vet Pharmacol Ther; 1996 Dec; 19(6):431-8. PubMed ID: 8971671
[TBL] [Abstract][Full Text] [Related]
9. Oral trimethoprim-sulphamethoxazole levels in stable HIV-infected children.
Zar HJ; Langdon G; Apolles P; Eley B; Hussey G; Smith P
S Afr Med J; 2006 Jul; 96(7):627-9. PubMed ID: 16909188
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of sulfamethoxazole in healthy Han volunteers living at plain and in native Han and Tibetan healthy volunteers living at high altitude].
Li XY; Liu YN; Li YP; Yuan M; Zhu JB
Yao Xue Xue Bao; 2011 Sep; 46(9):1117-22. PubMed ID: 22121785
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the pharmacokinetics of intravenous and oral trimethoprim/sulfadiazine formulations in the horse.
van Duijkeren E; Vulto AG; Sloet van Oldruitenborghoosterbaan MM; Mevius DJ; Kessels BG; Breukink HJ; van Miert AS
J Vet Pharmacol Ther; 1994 Dec; 17(6):440-6. PubMed ID: 7707489
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics and bioavailability of two cotrimoxazole preparations.
Pokrajac M; Miljković B; Simić D; Brzaković B; Galetin A
Pharmazie; 1998 Jul; 53(7):470-2. PubMed ID: 9699223
[TBL] [Abstract][Full Text] [Related]
13. A population pharmacokinetic model of trimethoprim in patients with pneumocystis pneumonia, made with parametric and nonparametric methods.
Jelliffe RW; Gomis P; Tahani B; Ruskin J; Sattler FR
Ther Drug Monit; 1997 Aug; 19(4):450-9. PubMed ID: 9263388
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and oral bioavailability of sulfadiazine and trimethoprim in broiler chickens.
Baert K; De Baere S; Croubels S; De Backer P
Vet Res Commun; 2003 May; 27(4):301-9. PubMed ID: 12872830
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioavailability of sulfadiazine and trimethoprim (trimazin 30%) after oral administration in non-fasted young pigs.
Baert K; De Baere S; Croubels S; Gasthuys F; De Backer P
J Vet Pharmacol Ther; 2001 Aug; 24(4):295-8. PubMed ID: 11555186
[No Abstract] [Full Text] [Related]
16. Quantification of co-trimoxazole in serum and plasma using MS/MS.
Dijkstra JA; Alsaad NS; Hateren Kv; Greijdanus B; Touw DJ; Alffenaar JW
Bioanalysis; 2015 Nov; 7(21):2741-9. PubMed ID: 26566213
[TBL] [Abstract][Full Text] [Related]
17. Three vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis.
Shahar E
JAMA; 1995 Nov; 274(17):1341; author reply 1341-2. PubMed ID: 7563550
[No Abstract] [Full Text] [Related]
18. Three vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis.
Sawyer J; Stryer D; Rydberg M; Polstein B
JAMA; 1995 Nov; 274(17):1341; author reply 1341-2. PubMed ID: 7563549
[No Abstract] [Full Text] [Related]
19. Trimethoprim/sulfamethoxazole: clinical update.
Libecco JA; Powell KR
Pediatr Rev; 2004 Nov; 25(11):375-80. PubMed ID: 15520082
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics of phenylbutazone in llamas following single intravenous and oral doses.
Navarre CB; Ravis WR; Nagilla R; Simpkins A; Duran SH; Pugh DG
J Vet Pharmacol Ther; 2001 Jun; 24(3):227-31. PubMed ID: 11442803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
